HIT Consultant June 24, 2025
What You Should Know:
– ForSight Robotics, the pioneer in ophthalmic robotic surgery secures $125M Series B round, led by Eclipse.
– The investment will accelerate the next growth phase for the ORYOM™ Platform, the world’s first robotic surgery platform for cataract and other eye diseases, as the company prepares to launch first-in-human clinical trials this year.
– The funding round, which brings ForSight Robotics’ total funding to $195M, also included significant participation from an undisclosed strategic investor, as well as Dr. Fred Moll, the Adani Group, Reiya Ventures, and other existing investors.
Addressing a Global Vision Crisis
The investment comes at a critical time, as a global vision crisis, marked by over one billion people suffering from...
Today's Sponsors
Today's Sponsor